Prof. Dr. Burçak Yılmaz is a nuclear medicine specialist focusing on radionuclide therapies, PET-CT and PET-MRI imaging and reporting, and conventional nuclear medicine imaging including SPECT/CT and gamma camera studies. She graduated as valedictorian from Bahçeşehir College before completing her medical education and residency in the Department of Nuclear Medicine at Istanbul University-Cerrahpaşa, later earning her PhD in Nuclear Medicine from the same institution and pursuing a further PhD in Molecular Oncology at the University of Health Sciences. Her career includes an observership at the University of Washington and a postdoctoral scholarship at Oregon Health and Science University, alongside academic and specialist roles across several Turkish institutions affiliated with the University of Health Sciences and Medipol University, before joining Biruni University Faculty of Medicine Hospital as Associate Professor. Her research has focused extensively on PSMA and FAPI PET/CT imaging in oncology, resulting in a substantial body of international peer-reviewed publications, including work published in the Journal of Nuclear Medicine. She is a member of the Turkish Nuclear Medicine Association and received a Certificate of Merit from the Radiological Society of North America (RSNA) in 2017.
Education
-
PhD, Nuclear Medicine
University of Health Sciences
2018–Present
-
PhD, Nuclear Medicine
Istanbul University-Cerrahpaşa
2012
-
Master's Degree (English Medicine Program)
Istanbul University-Cerrahpaşa
2006
-
Valedictorian (First Rank Graduation)
Bahçeşehir College
2000
Academic & Administrative Roles
-
Associate Professor (Nuclear Medicine)
Biruni University Faculty of Medicine Hospital
2025–Present
-
Postdoctoral Scholar
Oregon Health and Science University, Department of Nuclear Medicine
2023–2024
-
Associate Professor (Nuclear Medicine)
Medipol University Bahçelievler Hospital
2022–2023
-
Associate Professor (Training and Administrative Supervisor)
University of Health Sciences Başakşehir Çam and Sakura City Hospital, Nuclear Medicine Clinic
2020–2022
-
Associate Professor (Nuclear Medicine)
University of Health Sciences Istanbul Training and Research Hospital
2020
-
Observer Physician
University of Washington, Department of Nuclear Medicine
2017
-
Specialist Physician (Nuclear Medicine)
Training and Research Hospitals affiliated with the University of Health Sciences (Istanbul)
2012–2020
-
Resident Physician
Istanbul University-Cerrahpaşa, Department of Nuclear Medicine
2007–2012
- Turkish Nuclear Medicine Association
-
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients
Annals of Nuclear Medicine · 2022 -
Tumor imaging with 68Ga-DOTA-FAPI-04 PET/CT: comparison with 18F-FDG PET/CT in 22 different cancer types
Clinical Nuclear Medicine · 2022 -
68Ga-DOTA-FAPI-04 PET/CT in neuroendocrine carcinoma of the liver with elevated AFP level: comparison with 18F-FDG PET/CT
Clinical Nuclear Medicine · 2022 -
Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET: a different perspective with quantitative parameters
Nuclear Medicine Communications · 2022 -
Dual time point imaging of staging PSMA PET/CT quantification: spread and radiomic analyses
Annals of Nuclear Medicine · 2022 -
Tracheitis diagnosed with 68Ga-PSMA PET/CT in a patient with COVID-19
Clinical Nuclear Medicine · 2022 -
Adult tiger man: a case of dermatomyositis associated with thymoma
Clinical Nuclear Medicine · 2022 -
Effect of external cooling on 177Lu-PSMA uptake by parotid glands
Journal of Nuclear Medicine · 2019 -
The ability of pretreatment 18F-FDG PET/CT metabolic parameters for predicting axillary lymph node and distant metastasis and overall survival
Nuclear Medicine Communications · 2019 -
Comparison of preoperative locoregional 68Ga-PSMA-11 PET/CT and mp-MRI results with postoperative histopathology of prostate cancer
The Prostate · 2019 -
The efficacy of pretreatment and after-treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer
Nuclear Medicine Communications · 2019 -
PET/CT in the diagnosis and workup of sarcoidosis: focus on atypical manifestations
RadioGraphics · 2018 -
68Ga-PSMA-11 PET/CT in newly diagnosed prostate adenocarcinoma
Clinical Nuclear Medicine · 2018 -
Comparison of the prognostic value of 18F-FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
Brachytherapy · 2019 -
Comparison of day 3 and day 5 thyroglobulin results after Thyrogen injection in differentiated thyroid cancer patients
Therapeutic Advances in Endocrinology and Metabolism · 2018 -
Diagnostic value of 18F-FDG PET/CT in patients with spondylodiscitis: is dual time point imaging time worthy?
Diagnostic Microbiology and Infectious Disease · 2016 -
False-positive 68Ga-DOTATATE PET/CT in active chronic prostatitis
Clinical Nuclear Medicine · 2019 -
Subacute venous infarct mimicking cerebral metastasis in 18F-FDG PET/CT
Clinical Nuclear Medicine · 2019 -
Misleading 18F-FDG PET/CT finding caused by chronic HIV infection in a patient with gastric carcinoma: a case report
International Journal of STD & AIDS · 2018 -
Lacrimal gland uptake on 18F-florbetapir amyloid positron emission tomography scan
Radiology Case Reports · 2017 -
Surgical approach to anorectal melanoma with PET-CT staging: a case report
The Surgery Journal · 2017 -
Parasitic infestation mimicking hepatic metastasis with four different imaging modalities in a patient with breast carcinoma
The Breast Journal · 2017 -
Clinical, pathological and 18F-FDG PET/CT findings in synchronous primary vaginal and endometrial cancers
Hellenic Journal of Nuclear Medicine · 2016 -
Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma
Nuklearmedizin · 2023 -
Radiation-induced secondary lung cancer detected with 18F-FDG PET/CT 20 years after radiotherapy of breast cancer
SM Journal of Biomedical Engineering · 2017 -
Primary isolated breast lymphoma presenting as primary breast cancer with 18F-FDG PET/CT
Molecular Imaging and Radionuclide Therapy · 2023 -
Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule
npj Precision Oncology · 2024 -
Theranostics in neuroendocrine tumors: updates and emerging technologies
Current Problems in Cancer · 2024 -
The evaluation of external dose rate measurements of patients during and after 18F-FDG PET/CT imaging and appropriate discharge time from the PET/CT department
İstanbul Tıp Dergisi · 2019 -
The effect of transarterial Y-90 microsphere treatment of liver tumors on biochemical parameters
İstanbul Tıp Dergisi · 2019 -
Diagnostic accuracy of preoperative metabolic 18F-FDG PET/CT parameters for patients with endometrial cancer treated with postoperative radiation therapy
Çam and Sakura Medical Journal · 2021 -
Regression of hypermetabolic splenic granulomata mimicking metastases following non-targeted effect of radiotherapy for uterine cervical carcinoma
Çam and Sakura Medical Journal · 2021 -
Prognostic role of interleukin-23 in prostate adenocarcinoma: comparison with 68Ga-PSMA-11 PET/CT findings
İstanbul Tıp Dergisi · 2021 -
Diffuse bone marrow involvement of Langerhans cell histiocytosis detected with 18F-FDG PET/CT
Çam and Sakura Medical Journal · 2022
-
Certificate of Merit
Radiological Society of North America (RSNA), USA
2017
-
Best Resident Abstract
Western Regional Chapter of Society of Nuclear Medicine and Molecular Imaging, Vancouver, Canada
2023